Home > Insider Trading > Filing (0001179110-18-000779)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Gtx Inc	GTXI	Pharmaceutical Preparations (2834)	621715807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276242	Patton Henry Doggrell	175 Toyota Plaza 7Th Floor Memphis TN 38103	Vp, Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-01-05	1,142	$12.02	54,804	No	4	S	Direct
Common Stock	Disposition	2018-01-05	3,823	$11.13	50,981	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	400	Indirect	By IRA
Common Stock	664	Indirect	By Spouse
Common Stock	2,547	Indirect	By Spouse IRA
Common Stock	217	Indirect	By Trust
Common Stock	217	Indirect	By Trust
Common Stock	500	Indirect	By Trust

Footnotes

Shares sold to satisfy tax withholding obligations arising out of the vesting of a portion of previously granted restricted stock units.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.61 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.81 to $11.60, inclusive.
The reporting person disclaims beneficial ownership of these securities except to the extend of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for the purposes of Section 16 or any other purpose.